跳至主要内容
临床试验/JPRN-UMIN000043459
JPRN-UMIN000043459已完成未知

Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis - Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis

Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia0 个研究点目标入组 2,506 人开始时间: 2021年2月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,506

研究概览

简要总结

MWH administration was associated with a lower in-hospital mortality, and 28/30-day mortality compared with UFH administration. However, there was no difference in the incidence of bleeding with LMWH compared with UFH.

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
18years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • missing required data, no data on anticoagulant use, no outcome of interest, other than english language

研究者

发起方
Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

相似试验

Anticoagulation, Risk of Bleeding, and Overall... | 临床试验